The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

Merck KGaA, Darmstadt, Germany has closed the acquisition of SpringWorks Therapeutics Inc. for an enterprise value of $3.4 billion.